Image 1 of 4
Image 2 of 4
Image 3 of 4
Image 4 of 4
Packaging & supply options
Your format, your way.
The same research peptide, with a choice of accessories and supply formats. Here’s what each option includes.
BAC water
Vial kit
Lyophilised peptide vial with separately packaged, complimentary BAC water.
BAC water + syringes
Syringe kit
Lyophilised peptide vial, BAC water and syringes.
BAC water + pen
Injection pen kit
Lyophilised peptide vial, BAC water and an injection pen.
Pen + pen needles
Reconstituted pen
VIETNAM ONLYPeptide solution supplied in a pen at the stated concentration, with pen needles.
For laboratory research only. Not for human or veterinary use.
Everform Pharma · Thymic peptide research
Thymalin.
Exploring immune regulation.
A closer look at thymus-derived peptide preparations, inflammatory signalling and age-related immune research — with product identity and study limits in focus.
What is Thymalin?
In the cited literature, Thymalin is a thymus-derived polypeptide preparation. It is not described as one universally defined synthetic peptide sequence. Studies have investigated immune-related markers, inflammatory responses and outcomes in selected patient groups. [1] [2]
This distinction matters when comparing research products. A label carrying the same name does not, by itself, demonstrate the same source material, composition or biological activity as a preparation used in a published study.
The research name should also be distinguished from other thymic preparations and individual short peptides. Evidence for a component cannot automatically be applied to an entire mixture, or vice versa.
How it works
Research has explored whether thymic peptide preparations influence immune-cell activity and inflammatory signalling. Because Thymalin is described as a preparation containing multiple peptides, assigning it one sequence-specific receptor mechanism would be misleading.
Linkova and colleagues examined Thymalin and the short peptides KE and EW using computational methods and an inflammation model with human peripheral blood mononuclear cells. They reported reduced production of selected inflammatory cytokines in that laboratory setting. [1]
Computational binding predictions generate hypotheses; they do not establish a clinical mechanism. Likewise, a cytokine change in isolated cells does not show that a product prevents infection or produces the same response throughout a person’s body.
IMMUNE SIGNALLING
Studying cellular responses and inflammatory markers in defined experimental conditions.
PREPARATION IDENTITY
Checking the composition studied before transferring findings to another product.
Main research areas
| Research area | Evidence and limits |
|---|---|
| Inflammatory signalling | A laboratory study used stimulated human blood cells and computational modelling. This was not a clinical trial of infection prevention. [1] |
| Immune markers during illness | A clinical report examined Thymalin alongside standard care in older patients with severe COVID-19. Its findings concern a specific illness and treatment context. [2] |
| Age-related immune changes | A long-term report followed older adults receiving thymic and/or pineal preparations. Multiple groups and preparations complicate interpretation. [3] |
| Preparation and component research | Whole-preparation findings and results for isolated short peptides answer different questions. They do not demonstrate the identity or performance of a separate research vial. [1] |
Human-derived cells studied outside the body are not human clinical outcomes. The cited human studies do not establish general benefits in healthy adults.
What published findings show
Laboratory inflammatory-response model: The 2023 study by Linkova and colleagues used blood cells from four donors. Thymalin and the KE and EW peptides reduced selected cytokine measurements under stimulated conditions. This supports further mechanistic investigation, not a claim of universal immune enhancement. [1]
Severe illness in older patients: Kuznik and colleagues reported outcomes in 36 patients receiving Thymalin alongside standard therapy and 44 receiving standard therapy alone. They described changes in blood immune markers and clinical recovery. This relatively small clinical comparison does not establish efficacy across infections, healthy populations or different formulations. [2]
Long-term older-adult research: Khavinson and Morozov described 266 older adults followed for six to eight years in research involving Thymalin and Epithalamin. The authors reported favourable health and survival findings. The indexed abstract does not provide enough detail to establish allocation methods or blinding, and findings involving a different or combined preparation cannot all be attributed to Thymalin alone. [3]
These studies do not establish that an Everform research vial extends human lifespan, prevents infection or restores a youthful immune system. Larger, independently replicated studies using clearly characterised preparations would be needed to support broad clinical claims.
The Everform product, at a glance
Product labelThymalin
Labelled vial amount10 mg
Vial formatLyophilised powder
Supply optionsCheck the current product selector
Everform Pharma is based in Da Nang, Vietnam. The labelled 10 mg describes vial content, not a recommended dose. Complimentary BAC water is included with every order.
Explore Your format, your way →
Confirm the supplied material’s identity and composition in its documentation: whether it is an extract or a defined synthetic material, its source or manufacturing basis, and the basis for its labelled content. This profile does not assume equivalence to the thymus-derived preparations in the cited papers or assign a single sequence or molecular weight from the name alone.
The full REF on the product should match the relevant documentation. The security sticker repeats the product identifier and should match the vial or pen; it is not a separate new ID. Follow the actual product label for storage and expiry.
Identity, chromatographic purity and measured content are different analytical results. For a multi-component preparation, a single chromatographic peak percentage cannot by itself establish composition, potency or equivalence to a study preparation.
Common questions
Is Thymalin one defined synthetic peptide?
The cited papers describe a thymus-derived polypeptide preparation. Do not assume one universal sequence or molecular weight from the product name; check the supplied material’s documentation. [1] [2]
Do findings for KE or EW prove the effects of a Thymalin vial?
No. Isolated components and whole preparations differ. Findings must remain tied to the test material and experimental conditions. [1]
Does the research prove that Thymalin extends human lifespan?
No such conclusion is established for the Everform product. The older-adult report is hypothesis-generating and does not justify a general longevity promise. [3]
Is “immune boosting” an accurate description?
It is too broad. Research measures particular immune cells, cytokines or clinical outcomes. A change in one marker is not automatically a beneficial increase in immunity or protection from illness.
Does a pen photograph establish a validated formulation?
No. Packaging does not establish stability, compatibility, sterility, absorption or clinical performance. These require formulation-specific evidence and documentation.
Does 10 mg describe a recommended dose?
No. It is the labelled amount in the vial, not a dose, concentration, schedule or administration instruction.
References
Everform Pharma · Da Nang, Vietnam
Educational product information.
For laboratory research only.
Not for human or veterinary use.
